BiotechTube
Home/Pipeline/AC-1101

AC-1101

Autoimmune Inflammatory Skin Diseases

Phase 1/2Active

Key Facts

Indication
Autoimmune Inflammatory Skin Diseases
Phase
Phase 1/2
Status
Active
Company
TWi Biotechnology

About TWi Biotechnology

Taiwan biotech repurposing approved drugs for rare dermatologic and CNS indications.

View full company profile

Therapeutic Areas

DermatologyCNS DisordersRare DiseasesPsychiatryImmunology